From earlier work focused on muscular dystrophy conducted with former Penn Dental Medicine faculty member Elizabeth Barton, now at the University of Florida, the researchers believed that a particular form of IGF, a precursor of the protein that includes a separate component known as an e-peptide, was likely to stimulate regeneration better than mature IGF-1 that lacked the peptide
What sets Healthletic's version apart is its: Oral format (no needles) Verified ingredient quality Simplified daily dosing Transparency in sourcing and testing Disclaimer: BPC-157 is not an FDA-approved drug, and the Food and Drug Administration has not evaluated statements regarding its effects
This medication helps to release more insulin at lower doses and reduces appetite and boosts feelings of fullness at higher doses
This means you need concentrations that support single-draw dosing at these levels
Additionally, in practice, this means that two distinct end points should both be overwhelmed to produce the effects seen in rats that received BPC 157 application[3]
